(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RELAY THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RELAY THERAPEUTICS

ST13

US500000088979360

Class

42

Filing

88979360

Registration

6205848

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

11/25/2025

Trademark type

Combined

Nice classes

42

Filing date

10/26/2018

Registration date

11/24/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/24/2020

Last transaction

11/25/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2016-04-00

First use in commerce

09/14/2016

Drawing code

3

Owner type

03

Owner location

Cambridge, MA

Examiner

PEISECKI,MARK A

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a geometrical figure design, consisting of two quadrilaterals intersecting, to the left of the wording "RELAY" in large font above "THERAPEUTICS" in smaller font.

Holders and representatives

Holders

Relay Therapeutics, Inc.

Representatives

Jessica L. Rothstein GOODWIN PROCTER LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Biochemical research and development services in the field of allosteric regulation; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic products

Publications

History of USPTO decisions and trademark events.

42 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

11/24/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/04/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/04/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/04/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/04/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/04/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/24/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/22/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/21/2020

DPCC

DIVISIONAL PROCESSING COMPLETE

10/21/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/21/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/30/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

04/21/2020

DRRR

DIVISIONAL REQUEST RECEIVED

04/21/2020

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

04/21/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/17/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/17/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/17/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/17/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/17/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/17/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/19/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/24/2019

PUBO

PUBLISHED FOR OPPOSITION

09/24/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/04/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/21/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

08/17/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/17/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

08/17/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/17/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/25/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/24/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/24/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/01/2019

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/01/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/07/2019

GNRT

NON-FINAL ACTION E-MAILED

02/07/2019

CNRT

NON-FINAL ACTION WRITTEN

02/07/2019

DOCK

ASSIGNED TO EXAMINER

02/02/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/13/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/11/2018

NWAP

NEW APPLICATION ENTERED

10/30/2018

Continuous trademark protection

Get notified about every new filing that threatens RELAY THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.